Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin Pandian A; Arora A; Sperling LS; Khan BVVasc Health Risk Manag 2008[]; 4 (5): 1001-9Dyslipidemia is a major risk factor in the initiation and progression of cardiovascular diseases such as atherosclerosis. Several pharmacological agents have been developed over the past 50 years which target various lipid components such as low density lipoprotein (LDL) cholesterol, triglyceride, and high density lipoprotein (HDL) cholesterol. Similar to other risk factors such as hypertension and diabetes mellitus, the management of dyslipidemia can be complicated and may require combination therapy for effective treatment. This review discusses the biochemical mechanisms of action and clinical uses for simvastatin (the most widely available and commercially prescribed statin) and niacin, and the combination of these agents in the management and treatment of dyslipidemia.|Cardiovascular Diseases/etiology/*prevention & control[MESH]|Delayed-Action Preparations[MESH]|Drug Combinations[MESH]|Dyslipidemias/complications/*drug therapy[MESH]|Humans[MESH]|Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects/pharmacokinetics/*therapeutic use[MESH]|Hypolipidemic Agents/adverse effects/pharmacokinetics/*therapeutic use[MESH]|Niacin/adverse effects/pharmacokinetics/*therapeutic use[MESH]|Patient Compliance[MESH]|Simvastatin/adverse effects/pharmacokinetics/*therapeutic use[MESH]|Treatment Outcome[MESH] |
